Li et al. [128] reported that the YY1/HDAC2 complex in ccRCC inhibited the expression of YTHDC1, thereby affecting the expression of its downstream target gene ANXA1 and inhibiting the sensitivity of ccRCC to tyrosinase inhibitors. The gene discussed is ANXA1; the disease is nonpapillary renal cell carcinoma.